2012

While it has been a few months since the last large settlement involving the off-label promotion of pharmaceutical products, the…

Over the past few months, we have seen increased activity at the Food and Drug Administration (FDA) with respect to the issuance…

The Office of the Inspector General (OIG) for the Department of Health and Human Services (HHS) recently released the summary of a…

Sometime tonight or early tommorow, the 2012 Presidential election will be decided, and according to a recent article from…

In October 2008 the Centers for Medicare & Medicaid Services (CMS) discontinued additional payments for preventable…

One of the most controversial provisions from the Patient Protection and Affordable Care Act (ACA) is a provision that will impose…

Over the years, we have written about the relationships between the life sciences industry—manufacturers of pharmaceuticals,…

One of the central pieces of the Patient Protection and Affordable Care act was Section 3022, which created the added a new…

Over the past year, we have written several stories about the troubling drug shortages that have been occurring.  This summer,…

Nursing facility residents often experience potentially avoidable inpatient hospitalizations. These hospitalizations are…